OS Therapies Incorporated OSTX
1.66
0.00
0.00%
as of 25 Sep
- Market cap
- $77.7M
- P/E
- 0.0×
Follow OSTX
| Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
0.08 | 0.03 | 1.20 | 0.03 |
Net Debt/EBITDA |
(3.09) | 0.02 | 1.03 | 0.01 |
Debt/Assets |
2,032.53% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(0.59) | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.59 | 0.38 | 0.82 | 0.50 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 38.08% | 65.34% | 614.26% | |
| 0.00% | (1,211.23%) | (281.34%) | (464.58%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
113.14% | 33.10% | (977.97%) | 251.58% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.95 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.76) | (0.55) | (1.05) | (0.49) |
Cash per Share |
0.03 | 0.01 | 0.80 | 0.01 |
Shareholders Equity per Share |
(3.52) | (4.42) | 0.12 | (0.17) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(3.52) | (4.42) | 0.12 | (0.17) |
Free Cash Flow |
(3.79) | (3.01) | (7.28) | (14.24) |
Working Capital |
(5.65) | (23.92) | 0.91 | (11.43) |
Net Current Asset Value |
(17.57) | (24.02) | 0.81 | (11.53) |
| Other line items | ||||
Quick Ratio |
0.03 | 0.00 | 1.20 | 0.02 |
Depreciation/Fixed assets |
93.68 | 327.25 | 269.53 | 560.28 |
Cash ROIC |
54.06% | 12.57% | (114.86%) | 299.49% |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.76) | (0.55) | (1.05) | (0.49) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
— | 1.97 | 2.19 | 5.80 |
Average Assets |
— | 0.65 | 3.17 | 6.19 |
Average Common Equity |
— | (20.79) | (13.64) | (4.68) |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates